Cite
Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.
MLA
Tatovic, D., et al. “Stimulated Urine C-Peptide Creatinine Ratio vs Serum C-Peptide Level for Monitoring of β-Cell Function in the First Year after Diagnosis of Type 1 Diabetes.” Diabetic Medicine, vol. 33, no. 11, Nov. 2016, pp. 1564–68. EBSCOhost, https://doi.org/10.1111/dme.13186.
APA
Tatovic, D., Luzio, S., Dunseath, G., Liu, Y., Alhadj Ali, M., Peakman, M., Dayan, C. M., O’Keefe, A., Stenson, R., Pell, J., Howell, A., Arif, S., Bayly, G., Thorogood, N., Green, K., Andrews, R. C., McLintock, N., Leech, N., Kyne, D., & Joseph, F. (2016). Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes. Diabetic Medicine, 33(11), 1564–1568. https://doi.org/10.1111/dme.13186
Chicago
Tatovic, D., S. Luzio, G. Dunseath, Y. Liu, M. Alhadj Ali, M. Peakman, C. M. Dayan, et al. 2016. “Stimulated Urine C-Peptide Creatinine Ratio vs Serum C-Peptide Level for Monitoring of β-Cell Function in the First Year after Diagnosis of Type 1 Diabetes.” Diabetic Medicine 33 (11): 1564–68. doi:10.1111/dme.13186.